Erratum: Systemic gene delivery protects the photoreceptors in the retinal degeneration slow mouse (Neurochemical Research (2011) 36 (613-618) DOI:10.1007/s11064-010-0272-6);Systemic gene delivery protects the photoreceptors in the retinal degeneration slow mouse

Neurochemical Research

Volumn 36, Issue 4, 2011, Pages 613-618

  Sullivan, Tim ^a   Kodali, Kishore ^a   Rex, Tonia S ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Erythropoietin; Gene therapy; Neuroprotection; Retinal degeneration

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; ERYTHROPOIETIN; PARVOVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; EMBRYO; HEMATOCRIT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUTANT; NEUROPROTECTION; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; RETINA DEGENERATION; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

ADENO-ASSOCIATED VIRUS; MUS;

EID: 79954574434     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-012-0785-2     Document Type: Erratum

References (19)

1. RetNet (1996-2009). From http://www.sph.uth.tmc.edu/retnet/
2. A Rebuffat CO Harding Z Ding, et al. 2010 Comparison of adeno-associated virus pseudotype 1, 2, and 8 vectors administered by intramuscular injection in the treatment of murine phenylketonuria Hum Gene Ther 21 463 477 19916803 10.1089/hum.2009.127 1:CAS:528:DC%2BC3cXks1Grsbk%3D
3. W Banks N Jumbe C Farrell, et al. 2004 Passage of erythropoietic agents across the blood brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfa Eur J Pharmacol 505 93 101 15556141 10.1016/j.ejphar.2004.10.035 1:CAS:528:DC%2BD2cXhtVWjsLbL (Pubitemid 39535680)
4. A Xenocostas W Cheung F Farrell, et al. 2005 The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin Eur J Pharmacol 61 189 195 10.1007/s00228-005- 0896-7 1:CAS:528:DC%2BD2MXktlCntro%3D (Pubitemid 40768551)
5. P Statler R McPherson L Bauer, et al. 2007 Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats Ped Res 61 671 675 1:CAS:528:DC%2BD2sXlt1Cgurg%3D (Pubitemid 46800274)
6. M Gassmann K Heinicke J Soliz, et al. 2003 Non-erythroid functions of erythropoietin Adv Exper Med Biol 543 323 330 1:CAS:528:DC%2BD2cXnvVOksr8%3D (Pubitemid 38183733)
7. P Jubinsky O Krijanovski D Nathan, et al. 1997 The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor Blood 90 1867 1873 9292519 1:CAS:528:DyaK2sXls1Giur8%3D (Pubitemid 27377296)
8. M Brines G Grasso F Fiordaliso, et al. 2004 Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor Proc Natl Acad Sci USA 101 14907 14912 15456912 10.1073/pnas.0406491101 1:CAS:528:DC%2BD2cXovVyis7w%3D (Pubitemid 39410773)
9. M von Lindern W Zauner G Mellitzer, et al. 1999 The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro Blood 94 550 559 (Pubitemid 29323869)
10. E Stellacci A Di Noia A Di Baldassarre, et al. 2009 Interaction between the glucocorticoid and erythropoietin receptors in human erythroid cells Exp Hematol 37 559 572 19375647 10.1016/j.exphem.2009.02.005 1:CAS:528: DC%2BD1MXkslOjtLY%3D
11. J Weishaupt G Rohde E Polking, et al. 2004 Effect of erythropoietin on axotomy induced apoptosis in rat retinal ganglion cells Invest Ophthalmol Vis Sci 45 1514 1522 15111610 10.1167/iovs.03-1039 (Pubitemid 38859333)
12. C King J Rodger C Bartlett, et al. 2007 Erythropoietin is both neuroprotective and neuroregenerative following optic nerve transection Exper Neurol 205 48 55 10.1016/j.expneurol.2007.01.017 1:CAS:528:DC%2BD2sXkslOhs70%3D (Pubitemid 46617489)
13. U Kilic E Kilic J Soliz, et al. 2005 Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2 FASEB J 19 249 251 15556972 1:CAS:528:DC%2BD2MXhtFehs74%3D (Pubitemid 40189271)
14. H Wang ZL Liu XT Zhuang, et al. 2009 Neuroprotective effect of recombinant human erythropoietin on optic nerve injury in rats Chin Med J 122 2008 2012 19781386 1:CAS:528:DC%2BD1MXht1WqtbrM
15. L Zhong J Bradley W Schubert, et al. 2007 Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice Invest Ophthalmol Vis Sci 48 1212 1218 17325165 10.1167/iovs.06-0757 (Pubitemid 351261416)
16. TS Rex Y Wong K Kodali, et al. 2009 Neuroprotection of photoreceptors by direct delivery of erythropoietin to the retina of the retinal degeneration slow mouse Exp Eye Res 89 735 740 19591826 10.1016/j.exer.2009.06.017 1:CAS:528:DC%2BD1MXht1aisbrP
17. T Rex M Allocca L Domenici, et al. 2004 Systemic but not intraocular Epo gene transfer protects the retina from light-and genetic-induced degeneration Mol Ther 10 855 861 15509503 10.1016/j.ymthe.2004.07.027 1:CAS:528: DC%2BD2cXpt1Wjt7k%3D (Pubitemid 39419912)
18. M Leist P Ghezzi G Grasso, et al. 2004 Derivatives of erythropoietin that are tissue protective but not erythropoietic Science 305 239 242 15247477 10.1126/science.1098313 1:CAS:528:DC%2BD2cXlsV2gsbo%3D (Pubitemid 38886736)
19. Y Xiong A Mahmood C Qu, et al. 2010 Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor J Neurotrauma 27 205 215 19715391 10.1089/neu.2009.1001